MAGEA1 and Miyoshi myopathy: Subsequently, CTLs were challenged with peptide pools of TAA (PRAME, mucin-1 and MAGE-A1), which are commonly expressed in MM,30 and increased IFN-γ production was observed in response to PRAME and MAGE-A1 peptides (figure 6E).